Li Changlin, Zhou Le, Dionigi Gianlorenzo, Li Fang, Zhao Yishen, Sun Hui
From the Division of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Jilin Provincial Engineering Laboratory of Thyroid Disease Prevention and Control, Changchun, Jilin Province, China.
Division for Endocrine and Minimally Invasive Surgery, Department of Human Pathology in Adulthood and Childhood "G. Barresi," University Hospital G. Martino, University of Messina, Messina, Italy.
Endocr Pract. 2020 Aug;26(8):830-839. doi: 10.4158/EP-2020-0057.
We examined the relationships between tumor tissue calcifications of papillary thyroid cancer (PTC), body mass index (BMI), and tumor invasiveness.
This was a retrospective analysis of 13,995 patients with PTC. Comparisons were made between the clinical and pathologic features of the tumor tissue calcifications group and non-tumor tissue calcifications group. Odds ratios (ORs) of tumor tissue calcifications, BMI, and tumor invasiveness features were calculated using a binary logistic regression model. We analyzed the relationship between tumor tissue calcifications and certain characteristics of thyroid cancer based on the pathologic findings.
BMI was positively correlated with tumor tissue calcifications in patients with PTC (OR, 1.015; P = .011), and obesity increased the risk of tumor tissue calcifications (OR, 1.374; P = .038). Calcifications were positively correlated with T-size (OR, 1.899; P<.001), multifocality (OR, 1.217; P<.001), extrathyroidal extension (ETE) (OR, 1.287; P<.001), high T-stage (OR, 1.765; P<.001), N+ (OR, 1.763; P<.001), and a higher number of lymph node metastases (OR, 1.985; P<.001). Compared with normal-weight patients with tumor tissue calcifications, obese patients with tumor tissue calcifications had an increased risk of ETE (OR, 1.765 vs. OR, 1.300) and N+ (OR, 1.992 vs. OR, 1.784).
Tumor tissue calcifications are positively correlated with the invasiveness of PTC. Obesity further promotes the risk of tumor invasiveness in PTC combined with tumor tissue calcifications. These findings suggest that more comprehensive evaluations by trained pathologists may help physicians identify the optimal therapeutic regimens in the postoperative period.
BMI = body mass index; CI = confidence interval; ETE = extrathyroidal extension; FT3 = free triiodothyronine; OR = odds ratio; PTC = papillary thyroid carcinoma; RET = rearranged during transfection; TTC = tumor tissue calcification; US = ultrasonography; USC = ultrasonography calcification; WHO = World Health Organization.
我们研究了甲状腺乳头状癌(PTC)的肿瘤组织钙化、体重指数(BMI)与肿瘤侵袭性之间的关系。
这是一项对13995例PTC患者的回顾性分析。对肿瘤组织钙化组和非肿瘤组织钙化组的临床和病理特征进行了比较。使用二元逻辑回归模型计算肿瘤组织钙化、BMI和肿瘤侵袭性特征的比值比(OR)。我们根据病理结果分析了肿瘤组织钙化与甲状腺癌某些特征之间的关系。
PTC患者的BMI与肿瘤组织钙化呈正相关(OR,1.015;P = 0.011),肥胖增加了肿瘤组织钙化的风险(OR,1.374;P = 0.038)。钙化与T大小(OR,1.899;P<0.001)、多灶性(OR,1.217;P<0.001)、甲状腺外扩展(ETE)(OR,1.287;P<0.001)、高T分期(OR,1.765;P<0.001)、N+(OR,1.763;P<0.001)以及更多的淋巴结转移数量(OR,1.985;P<0.001)呈正相关。与有肿瘤组织钙化的正常体重患者相比,有肿瘤组织钙化的肥胖患者发生ETE(OR,1.765对OR,1.300)和N+(OR,1.992对OR,1.784)的风险增加。
肿瘤组织钙化与PTC的侵袭性呈正相关。肥胖进一步增加了PTC合并肿瘤组织钙化时肿瘤侵袭的风险。这些发现表明,由训练有素的病理学家进行更全面的评估可能有助于医生确定术后的最佳治疗方案。
BMI = 体重指数;CI = 置信区间;ETE = 甲状腺外扩展;FT3 = 游离三碘甲状腺原氨酸;OR = 比值比;PTC = 甲状腺乳头状癌;RET = 转染重排;TTC = 肿瘤组织钙化;US = 超声检查;USC = 超声钙化;WHO = 世界卫生组织